SEC Filings

10-Q
MEDTRONIC PLC filed this Form 10-Q on 09/01/2017
Entire Document
 
Medtronic plc
Notes to Consolidated Financial Statements
(Unaudited)


Condensed Consolidating Statement of Cash Flows
Three Months Ended July 29, 2016
Medtronic Senior Notes

(in millions)
Medtronic plc
 
Medtronic, Inc.
 
Medtronic Luxco
 
Subsidiary Non-guarantors
 
Consolidating
Adjustments
 
Total
Operating Activities:
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$
440

 
$
534

 
$
13

 
$
563

 
$

 
$
1,550

Investing Activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisitions, net of cash acquired

 

 

 
(12
)
 

 
(12
)
Additions to property, plant, and equipment

 

 

 
(330
)
 

 
(330
)
Purchases of investments

 

 

 
(1,206
)
 
162

 
(1,044
)
Sales and maturities of investments

 
162

 

 
1,104

 
(162
)
 
1,104

Net (increase) decrease in intercompany loans

 
(541
)
 
(1,787
)
 
(785
)
 
3,113

 

Capital contribution paid

 
(162
)
 

 

 
162

 

Other investing activities, net

 

 

 
(2
)
 

 
(2
)
Net cash provided by (used in) investing activities

 
(541
)
 
(1,787
)
 
(1,231
)
 
3,275

 
(284
)
Financing Activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisition-related contingent consideration

 

 

 
(11
)
 

 
(11
)
Change in current debt obligations, net

 

 
975

 
(49
)
 

 
926

Issuance of long-term debt

 

 

 
33

 

 
33

Payments on long-term debt

 

 

 
(17
)
 

 
(17
)
Dividends to shareholders
(599
)
 

 

 

 

 
(599
)
Issuance of ordinary shares
214

 

 

 

 

 
214

Repurchase of ordinary shares
(1,763
)
 

 

 

 

 
(1,763
)
Net intercompany loan borrowings (repayments)
1,708

 
(2
)
 
854

 
553

 
(3,113
)
 

Capital contribution received

 

 

 
162

 
(162
)
 

Other financing activities

 

 

 
57

 

 
57

Net cash provided by (used in) financing activities
(440
)
 
(2
)
 
1,829

 
728

 
(3,275
)
 
(1,160
)
Effect of exchange rate changes on cash and cash equivalents

 

 

 
78

 

 
78

Net change in cash and cash equivalents

 
(9
)
 
55

 
138

 

 
184

Cash and cash equivalents at beginning of period

 
55

 

 
2,821

 

 
2,876

Cash and cash equivalents at end of period
$

 
$
46

 
$
55

 
$
2,959

 
$

 
$
3,060



39

X